PHARMACYTE BIOTECH, INC. (PMCB) Stock buybacks 2022–2026
PHARMACYTE BIOTECH, INC. (PMCB) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$401,625FY2026 · since FY2022: $0 → $401,625
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $401,625 | -84.2% |
| FY2025 | $2.5M | -91.0% |
| FY2024 | $28.2M | +107.9% |
| FY2023 | $13.6M | — |
| FY2022 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice